- Home
- FBGL vs IMRN Comparison
FBGL vs IMRN Comparison
Compare FBGL & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBGL
- IMRN
- Stock Information
- Founded
- FBGL 1996
- IMRN 1994
- Country
- FBGL Singapore
- IMRN Australia
- Employees
- FBGL N/A
- IMRN N/A
- Industry
- FBGL Miscellaneous manufacturing industries
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- FBGL Consumer Discretionary
- IMRN Health Care
- Exchange
- FBGL Nasdaq
- IMRN Nasdaq
- Market Cap
- FBGL 7.8M
- IMRN 9.2M
- IPO Year
- FBGL 2025
- IMRN N/A
- Fundamental
- Price
- FBGL $0.66
- IMRN $1.70
- Analyst Decision
- FBGL
- IMRN Strong Buy
- Analyst Count
- FBGL 0
- IMRN 1
- Target Price
- FBGL N/A
- IMRN $5.00
- AVG Volume (30 Days)
- FBGL 143.2K
- IMRN 53.0K
- Earning Date
- FBGL 01-01-0001
- IMRN 06-17-2025
- Dividend Yield
- FBGL N/A
- IMRN N/A
- EPS Growth
- FBGL N/A
- IMRN N/A
- EPS
- FBGL N/A
- IMRN N/A
- Revenue
- FBGL $10,146,582.00
- IMRN $4,048,286.00
- Revenue This Year
- FBGL N/A
- IMRN N/A
- Revenue Next Year
- FBGL N/A
- IMRN N/A
- P/E Ratio
- FBGL N/A
- IMRN N/A
- Revenue Growth
- FBGL N/A
- IMRN 82.90
- 52 Week Low
- FBGL $0.44
- IMRN $1.50
- 52 Week High
- FBGL $5.45
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- FBGL N/A
- IMRN 43.37
- Support Level
- FBGL N/A
- IMRN $1.69
- Resistance Level
- FBGL N/A
- IMRN $1.89
- Average True Range (ATR)
- FBGL 0.00
- IMRN 0.17
- MACD
- FBGL 0.00
- IMRN -0.01
- Stochastic Oscillator
- FBGL 0.00
- IMRN 34.06
About FBGL FBS Global Limited Ordinary Shares
FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.